Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade

Journal of Neuro-Oncology

Volumn 97, Issue 3, 2010, Pages 353-364

  Rousseau, Audrey ^a,b   Idbaih, Ahmed ^a   Ducray, François ^a   Criniére, Emmanuelle ^a   Févre Montange, Michéle ^c   Jouvet, Anne ^c,d   Delattre, Jean Yves ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSERM   (France)

^d HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Array CGH; Chromosomal imbalances; Ependymoma; Location; Myxopapillary; WHO grade

Indexed keywords

1 MEGABASE RESOLUTION ARRAY COMPARATIVE GENOMIC HYBRIDIZATION; ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; CANCER GRADING; CHILD; CHROMOSOME 10Q; CHROMOSOME 12; CHROMOSOME 15; CHROMOSOME 16; CHROMOSOME 18; CHROMOSOME 1Q; CHROMOSOME 22; CHROMOSOME 5; CHROMOSOME 6Q; CHROMOSOME 7; CHROMOSOME 9; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; EPENDYMOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NUMERICAL CHROMOSOME ABERRATION; OVERALL SURVIVAL; POSTERIOR CRANIAL FOSSA TUMOR; SPINAL CORD EPENDYMOMA; SUPRATENTORIAL EPENDYMOMA; TUMOR CLASSIFICATION; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES; COMPARATIVE GENOMIC HYBRIDIZATION; EPENDYMOMA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; YOUNG ADULT;

EID: 77953291821     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-0039-6     Document Type: Article

References (38)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) (2007) World Health Organization Classification of Tumours. Pathology and genetics of tumours of the nervous system. IARC, Lyon
2. Figarella-Branger D, Metellus P, Barrié M, Maues de Paula A, Fernandez C, Polivka M, Vital A, Labrousse F, Vignaud JM, Laquerrière A, Rousselet MC, Lacroix C, Saikaki S, Chapon F, Gontier MF, Chrétien F, Babin P, Rigau V, Vandenbos F, Peoc'h M, Kujas M, Chinot O, Gouvernet J, Giorgi R, Guyotat J, Jouvet A (2007) Intracranial ependymomas in adult patients. Diagnosis and histological prognostic factors. Neurochirurgie 53:76-84
3. Kleihues P, Cavenee WK (eds) (2000) World Health Organization Classification of Tumours. Pathology and genetics of tumours of the nervous system. IARC, Lyon
4. Neuvial P, Hupé P, Brito I, Liva S, Manié E, Brennetot C, Radvanyi F, Aurias A, Barillot E (2006) Spatial normalization of array-CGH data. BMC Bioinform 7:264
5. Hupe P, Stransky N, Thiery JP, Radvanyi F, Barillot E (2004) Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics 20:3413-3422
6. Janoueix-Lerosey I, Hupé P, Maciorowski Z, La Rose P, Schleiermacher G, Pierron G, Liva S, Barillot E, Delattre O (2005) Preferential occurrence of chromosome breakpoints within early replicating regions in neuroblastoma. Cell Cycle 4:1842-1846
7. Idbaih A, Marie Y, Lucchesi C, Pierron G, Manié E, Raynal V, Mosseri V, Hoang-Xuan K, Kujas M, Brito I, Mokhtari K, Sanson M, Barillot E, Aurias A, Delattre JY, Delattre O (2008) BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas. Int J Cancer 122:1778-1786
8. Hirose Y, Aldape K, Bollen A, James CD, Brat D, Lamborn K, Berger M, Feuerstein BG (2001) Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. Am J Pathol 158:1137-1143
9. Carter M, Nicholson J, Ross F, Crolla J, Allibone R, Balaji V, Perry R, Walker D, Gilbertson R, Ellison DW (2002) Genetic abnormalities detected in ependymomas by comparative genomic hybridization. Br J Cancer 86:929-939
10. Reardon DA, Entrekin RE, Sublett J, Ragsdale S, Li H, Boyett J, Kepner JL, Look AT (1999) Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma. Genes Chromosomes Cancer 24:230-237
11. Mendrzyk F, Korshunov A, Benner A, Toedt G, Pfister S, Radlwimmer B, Lichter P (2006) Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma. Clin Cancer Res 12:2070-2079
12. Pezzolo A, Capra V, Raso A, Morandi F, Parodi F, Gambini C, Nozza P, Giangaspero F, Cama A, Pistoia V, Garrè ML (2008) Identification of novel chromosomal abnormalities and prognostic cytogenetics markers in intracranial pediatric ependymoma. Cancer Lett 261:235-243
13. Ammerlaan AC, de Bustos C, Ararou A, Buckley PG, Mantripragada KK, Verstegen MJ, Hulsebos TJ, Dumanski JP (2005) Localization of a putative low-penetrance ependymoma susceptibility locus to 22q11 using a chromosome 22 tiling-path genomic microarray. Genes Chromosomes Cancer 43:329-338
14. Modena P, Lualdi E, Facchinetti F, Veltman J, Reid JF, Minardi S, Janssen I, Giangaspero F, Forni M, Finocchiaro G, Genitori L, Giordano F, Riccardi R, Schoenmakers EF, Massimino M, Sozzi G (2006) Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. J Clin Oncol 24:5223-5232
15. Gilhuis HJ, van der Laak J, Wesseling P, Boeman RH, Beute G, Teepen JL, Grotenhuis JA, Kappelle AC (2004) Inverse correlation between genetic aberrations and malignancy grade in ependymal tumors: a paradox? J Neurooncol 66:111-116
16. Scheil S, Brüderlein S, Eicker M, Herms J, Herold-Mende C, Steiner HH, Barth TF, Möller P (2001) Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization. Brain Pathol 11:133-143
17. Jeuken JW, Sprenger SH, Gilhuis J, Teepen HL, Grotenhuis AJ, Wesseling P (2002) Correlation between localization, age, and chromosomal imbalances in ependymal tumours as detected by CGH. J Pathol 197:238-244
18. Chessells JM, Swansbury GJ, Reeves B, Bailey CC, Richards SM (1997) Cytogenetics and prognosis in childhood lymphoblastic leukemia: results of MRC UKALL X Medical Research Council Working Party in Childhood Leukemia. Br J Hematol 99:93-100
19. Plantaz D, Mohapatra G, Matthay KK, Pellarin M, Seeger RC, Feuerstein BG (1997) Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol 150:81-89
20. Kaneko Y, Knudson AG (2000) Mechanism and relevance of ploidy in neuroblastoma. Genes Chromosomes Cancer 29:89-95
21. Vandesompele J, Speleman F, van Roy N, Laureys G, Brinskchmidt C, Christiansen H, Lampert F, Lastowska M, Bown N, Pearson A, Nicholson JC, Ross F, Combaret V, Delattre O, Feuerstein BG, Plantaz D (2001) Multicenter analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: how many genetic sub-groups are there? Med Pediatr Oncol 36:5-10
22. Dyer S, Prebble E, Davison V, Davies P, Ramani P, Ellison D, Grundy R (2002) Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups. Am J Pathol 161:2133-2141
23. Grill J, Avet-Loiseau H, Lellouch-Tubiana A, Sévenet N, Terrier- Lacombe MJ, Vénuat AM, Doz F, Sainte-Rose C, Kalifa C, Vassal G (2002) Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomas. Cancer Genet Cytogenet 136:121-125
24. Ward S, Harding B, Wilkins P, Harkness W, Hayward R, Darling JL, Thomas DG, Warr T (2001) Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma. Genes Chromosomes Cancer 32:59-66
25. Shlomit R, Ayala AG, Michal D, Ninett A, Frida S, Boleslaw G, Gad B, Gideon R, Shlomi C (2000) Gains and losses of DNA sequences in childhood brain tumors analyzed by comparative genomic hybridization. Cancer Genet Cytogenet 121:67-72
26. Kondo K, Chilcote RR, Maurer HS, Rowley JD (1984) Chromosome abnormalities in tumor cells from patients with sporadic Wilm's tumor. Cancer Res 44:5376-5381
27. Douglass EC, Rowe ST, Valentine M, Parham D, Meyer WH, Thompson EI (1990) A second nonrandom translocation, der(16)t(1;16)(q21;q13), in Ewing sarcoma and peripheral neuroectodermal tumor. Cytogenet Cell Genet 53:87-90
28. Mugneret F, Sidaner I, Favre B, Manone L, Maynadié M, Caillot D, Solary E (1995) Der(16)t(1;16)(q10;q10) in multiple myeloma: a new nonrandom abnormality that is frequently associated with Burkitt's type translocation. Leukemia 9:277-281
29. Mazewski C, Soukup S, Ballard E, Gotwals B, Lampkin B (1999) Karyotype studies in 18 ependymomas with literature review of 107 cases. Cancer Genet Cytogenet 113:1-8
30. Zheng PP, Pang JC, Hui AB, Ng HK (2000) Comparative genomic hybridization detects losses of chromosomes 22 and 16 as the most common recurrent genetic alterations in primary ependymomas. Cancer Genet Cytogenet 122:18-25
31. Huang B, Starostik P, Schraut H, Krauss J, Sörensen N, Roggendorf W (2003) Human ependymomas reveal frequent deletions on chromosomes 6 and 9. Acta Neuropathol 106:357-362
32. Wan M, Sun T, Vyas R, Zheng J, Granada E, Dubeau L (1999) Suppression of tumorigenicity in human ovarian cancer cell lines is controlled by a 2-cM fragment in chromosomal region 6q24- q25. Oncogene 18:1545-1551
33. Hamilton RL, Pollack IF (1997) The molecular biology of ependymomas. Brain Pathol 7:807-822
34. Duerr EM, Rollbrocker B, Hayashi Y, Peters N, Meyer-Puttlitz B, Louis DN, Schramm J, Wiestler OD, Parson R, Eng C, von Deimling A (1998) PTEN mutations in gliomas and glioneuronal tumors. Oncogene 16:2259-2264
35. Ebert C, von Haken M, Meyer-Puttlitz B, Wiestler OD, Reifenberger G, Pietsch T, von Deimling A (1999) Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. Am J Pathol 155:627
36. Tong CY, Ng HK, Pang JC, Hui AB, Ko HC, Lee JC (1999) Molecular genetic analysis of non-astrocytic gliomas. Histopathology 34:331-341
37. Taylor MD, Poppleton H, Fuller C, Su X, Liu Y, Jensen P, Magdaleno S, Dalton J, Calabrese C, Board J, Macdonald T, Rutka J, Guha A, Gajjar A, Curran T, Gilbertson RJ (2005) Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 8:323-335
38. Poppleton H, Gilbertson RJ (2007) Stem cells of ependymoma. Br J Cancer 96:6-10